MERLIN brochure and flyer are now available here.
The hepatology team at the John Radcliffe Hospital in Oxford are hosting an Open Forum for patients, carers, medical professionals on the latest developments in liver research on Wednesday 29 April.
More information is available on the PSC Support page.
Congratulations to Dr. Elliman and his team at Orbsen Therapeutics for their nomination for Spin-Out Company Impact Award, an annual Knowledge Transfer Ireland Impact Award.
“We are honoured to be nominated for KTI Spin-out Company of the Year. It recognises the huge efforts made by our own research team and our network of research partners to move Orbcel to the clinic so efficiently. Also, we are grateful to NUI Galway for their support over the years. The TTO have been instrumental in our progress to this point and we continue to enjoy working with them.” – Dr. Elliman
You can read more here.
The MERLIN team met in Rotterdam 12 – 13 February 2015 to discuss progress in the first year of the project, and to make plans for the coming year. We’ve learned more about how MSC work in our in vitro and in vivo studies, and planning is well underway for the planned clinical trial with PSC patients.
We were joined by the Scientific Advisory Board, who added their expert insights to our discussions.
Professor Ansgar Lohse,University Medical Center Hamburg-Eppendorf (Chair) – Expertise: Autoimmune liver disease & Liver immunology; Professor Willem Fibbe, Leiden University Medical Center – Expertise: Mesenchymal stromal cells; Dr. Neil Henderson, University of Edinburgh – Expertise: Liver fibrosis and stellate cells; Professor Tom Karlsen, Oslo University Hospital – Expertise: Primary Sclerosing Cholangitis; Professor Massimo Pinzani, University College London – Expertise: Liver fibrosis.
MERLIN has now been added to EuroStemCell’s Connections. EuroStemCell is a European partnership of scientists, clinicians, ethicists, social scientists and science communicators. Launched in March 2010, the partnership unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science.
MERLIN researcher Gideon Hirschfield of the University of Birmingham gave a talk about current and future therapies for PSC to patients. Watch a video of the presentation here.
MERLIN researcher Steve Elliman of Orbsen Therapeutics presented at the 8th Annual UK MSC meeting hosted by REMEDI in Galway 29 – 30 Oct, 2014. To read more about the conference, and to see a list of the other speakers, click here.
A new page dedicated to related publications has now gone live on the MERLIN site. This page can be accessed by following this link, and it will be updated throughout the project.
- The @FP7Merlin #clinicaltrial: NOW RECRUITING It is designed to: i) Determine dose safety of ORBCEL-C (selected Me… t.co/DNXAZmFZeK Time ago 23 Days via Twitter Web Client
- RT @unibirm_MDS: Project MERLIN, a new trial coordinated by @CRCTU @ImmunologyUoB, is recruiting up to 56 patients to investigate the safet… Time ago 34 Days via Twitter for iPhone
- RT @unibirm_MDS: A new cell therapy for chronic #liverdisease is being trialled as part of @fp7merlin by @CRCTU @ImmunologyUoB. It’s hoped… Time ago 38 Days via Twitter for iPhone
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.